Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breastcancer × Trastuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 70 Neoplasm Metastasis 12 Stomach Neoplasms 11 Breast Neoplasms, Male 8 Neoplasms 7 Endometrial Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 5 Esophageal Neoplasms 5 Ovarian Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Vulvar Neoplasms 2 Vipoma 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Somatostatinoma 2 Solid Tumor 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pleural Effusion, Malignant 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03014076 2017-01-09

Immunotherapy Vaccine and Herceptin in Breast Cancer

Cancer Insight, LLC

Phase 1 Completed

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡